@article {1604,
	title = {Derivation of iPSC lines from two patients with familial Alzheimer{\textquoteright}s disease from India.},
	journal = {Stem Cell Res},
	volume = {34},
	year = {2019},
	month = {2019 Jan},
	pages = {101370},
	abstract = {<p>The current prevalence of diagnosable dementia in India is 1\% of people over 60 years (~3.7 million people), but is estimated to increase significantly, as ~15\% world{\textquoteright}s aged population (\&gt;65 years) would be resident here by 2020 (Shah et al., 2016). While several mutations that pose a familial risk have been identified, the ethnic background may influence disease susceptibility, clinical presentation and treatment response. In this study, we report a detailed characterization of two representative HiPSC lines from a well-characterized dementia cohort from India. Availability of these lines, and associated molecular and clinical information, would be useful in the detailed exploration of the genomic contribution(s) to AD.</p>
},
	issn = {1876-7753},
	doi = {10.1016/j.scr.2018.101370},
	author = {Najar, Ashaq H and Sneha, K M and Ashok, Aparna and Babu, Swathy and Subramaniam, Anand G and Kannan, Ramkrishnan and Viswanath, Biju and Purushottam, Meera and Varghese, Mathew and Parvez, Suhel and Panicker, Mitradas M and Mukherjee, Odity and Jain, Sanjeev}
}
